000 01408 a2200385 4500
005 20250517112517.0
264 0 _c20180827
008 201808s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2016.67.0554
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaxwell, Kara N
245 0 0 _aPopulation Frequency of Germline BRCA1/2 Mutations.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_c12 2016
300 _a4183-4185 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aBRCA1 Protein
_xgenetics
650 0 4 _aBRCA2 Protein
_xgenetics
650 0 4 _aDNA Mutational Analysis
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenetic Testing
_xmethods
650 0 4 _aGerm-Line Mutation
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMutation Rate
650 0 4 _aNeoplasms
_xdiagnosis
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
700 1 _aDomchek, Susan M
700 1 _aNathanson, Katherine L
700 1 _aRobson, Mark E
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 34
_gno. 34
_gp. 4183-4185
856 4 0 _uhttps://doi.org/10.1200/JCO.2016.67.0554
_zAvailable from publisher's website
999 _c26351378
_d26351378